Discover the latest research at our Top 10 Poster Presentations. Each presenter will have 3 minutes to present and 2 minutes for Q&A, offering a quick yet insightful look at their studies.

๐Ÿ“ฑ Vote for the Best Poster via the ICLE 2026 mobile app and help select the top research! The winners will be announced during the closing session.

Date: 16 July
Time: 12:40 โ€“ 13:50
Location: Exhibition Hall

Katia Palmisano

IRCCS San Raffaele Scientific Institute
Italy

COMBINATORIAL STRATEGY FOR IMPROVED CDH17 CAR T CELL THERAPY OF LIVER METASTASES FROM COLORECTAL CANCER

๐Ÿ•› 12:40 โ€“ 12:45

Christian Pellegrino

Philochem AG
Switzerland

IMPROVED CAR T-CELL EFFECTIVENESS AGAINST SOLID TUMORS BY TUMOR-RESTRICTED CYTOKINE DELIVERY VIA IMMUNOCYTOKINES
๐Ÿ•› 12:45 โ€“ 12:50
Kathrin Gabriel

LMU Klinikum
Germany

A MODULAR CAR T CELL PLATFORM FOR TARGETED IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIA

๐Ÿ•› 12:50 โ€“ 12:55

Elise Sylvander

BOKU Vienna
Austria

CAFFEINE-REGULATED MOLECULAR SWITCHES FOR FUNCTIONAL CONTROL OF CAR T CELLS

๐Ÿ•› 12:55 โ€“ 13:00

Emilia Vigolo

Veneto Institute of Oncology – IOV
Italy

BREAKING THE MATRIX BARRIER: ENHANCING CAR-T CELL ACCESS TO SOLID TUMORS

๐Ÿ•› 13:00 โ€“ 13:05

Kersten M. Heyer

Technical University of Munich
Germany

ULTRA-DEEP MURINE EPITOPE-SPECIFIC TCR LIBRARIES IDENTIFY DISPARATE CONTRIBUTIONS OF T CELL RECEPTOR CHAINS AS A COMMON MODE OF FUNCTIONAL EPITOPE RECOGNITION

๐Ÿ•› 13:05 โ€“ 13:10

Chiara Chiavelli

University of Modena and Reggio Emilia
Italy

ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET EWINGโ€™S SARCOMA

๐Ÿ•› 13:10 โ€“ 13:15

Pinar Ataca Atilla

University of Miami
United States of America

TROGOCYTOSIS AND THE PARADOXIMAL IMPACT OF GAMMA SECRETASE INHIBITION ON BCMA CAR T CELLS

๐Ÿ•› 13:15 โ€“ 13:20

Koramit Suppipat

Chulalongkorn University
Thailand

LOCOREGIONAL IL-7Rฮ‘โ€“ENHANCED B7-H3 CAR T CELLS (CMD03) IN PEDIATRIC DIPG: PRELIMINARY RESULTS FROM A PHASE I DOSE-ESCALATION TRIAL

๐Ÿ•› 13:20 โ€“ 13:25

Maria Chiara Maffia

San Raffaele Scientific Institute
Italy

SINGLE-CELL PROFILING GUIDES A DISEASE-TAILORED TCR-BASED IMMUNOTHERAPY FOR EPITHELIAL OVARIAN CANCER

๐Ÿ•› 13:25 โ€“ 13:30

REGISTER HERE
EXPLORE PROGRAM